Veterinary Biologics Market - Trends Forecast Till 2028

Veterinary Biologics Market by Product (Vaccines, Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Animal Type (Companion Animals, Canine, Avian, Feline, Livestock), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: January, 2022

Base Year Estimate: 2021

Report ID: D-HC-VBM-1110

Format:  

Number of Pages: 412

Domain: Healthcare

Veterinary Biologics Market – Trends Forecast Till 2028

The Veterinary Biologics market size is projected to reach a CAGR of 6.6% from 2022 to 2028.

Veterinary Biologics are basically antigen, antitoxin and vaccine manufactured from the living organisms. Biologics are such that they leave no residue in the body of the animal. Animal and Plant Health Inspection Service (APHIS) is the regulatory body that licence and ensures the safety, purity and effectiveness of the biologics.

Increase R&D in the sector along with the pet owner being more aware and concerned about the pet health are some of the factors that have supported long-term expansion for Veterinary Biologics Market.

COVID-19 had a positive effect on the market, as the pet owners were more aware and concerned about their pets ever then before.

Veterinary Biologics Market Analysis Report

North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the favourable governmental policies along with people getting more concerned about their pets.

Veterinary Biologics Market is segmented into product, animal type, disease type, distribution channel and region.

On the basis of Product

  • Vaccines
    • Inactivated Vaccines
    • Conjugate Vaccines
    • Live Attenuated
    • Toxoid Vaccines
  • Diagnostic Kits
  • Immunomodulators
  • Antiserums & Antibodies
  • Others                                                      

On the basis of Animal Type

  • Livestock Animals
  • Companion Animals

On the basis of Disease Type

  • Bluetongue
  • Foot & Mouth Disease
  • Brucellosis & Tuberculosis
  • Others

On the basis of Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Veterinary Biologics Market Primary Respondent

Key Players

  • Zoetis, Inc.
  • Merck Animal Health
  • Boehringer Ingelheim GmbH
  • Bayer AG, Eli Lilly & Company
  • Abaxis
  • OMEGA
  • Hebei Veyong Animal Pharmaceutical Co., Ltd.
  • Other prominent players

Recent Developments

  • In November 2021, VETIGENICS signed a collaboration With Merck Animal Health.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Veterinary Biologics Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Growth Rate

CAGR of 6.6% during the forecasting period, 2022-2028

Historical Data

2019-2020

Forecast Years

2022-2028

Base Year

2021

Units Considered

Revenue in USD billion and CAGR from 2022 to 2028

Report Segmentation

Product, animal type, disease type, distribution channel and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, Hebei Veyong Animal Pharmaceutical Co., Ltd., Other prominent players

Available Customization

In addition to the market data for Veterinary Biologics  Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.